A cross-sectional study of COPD and symptom variability in MEA countries - COPVAR

Study identifier:D2287R00105

ClinicalTrials.gov identifier:NCT03425760

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A cross-sectional study of COPD and symptom variability in MEA countries

Medical condition

Chronic Obstructive Pulmonary Disease

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

3254

Study type

Observational

Age

N/A

Date

Study Start Date: 07 Dec 2015
Primary Completion Date: 31 Mar 2017
Study Completion Date: 31 Mar 2017

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jun 2018 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria